Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1/2 1

Status

Recruiting 18Completed 13Active not recruiting 12Terminated 8Unknown 5Withdrawn 3Not yet recruiting 3

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 17Dermatologic 10Thoracic 8Breast 7Head & Neck 5Gynecologic 5Genitourinary 5Other hematologic neoplasm 3Sarcoma 2NET 2Lymphoid 2Endocrine 2Tumor-Agnostic 1Other neoplasm 1Myeloid 1

Conditions

Head and Neck Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Thyroid Neoplasms 1Thyroid Diseases 1Oropharyngeal Neoplasms 1

Interventions

Cisplatin 108Radiotherapy 45Docetaxel 44Radiotherapy, Intensity-Modulated 36Gemcitabine 31Fluorouracil 30camrelizumab 24toripalimab 21Drug Therapy 21Cetuximab 20apatinib 19Paclitaxel 16Carboplatin 16pembrolizumab 14Chemoradiotherapy 14Capecitabine 13Blood Specimen Collection 13sintilimab 12nimotuzumab 12Surveys and Questionnaires 10Surgical Procedures, Operative 10Endostatins 10Cyclophosphamide 9nedaplatin 8endostar protein 8durvalumab 8Nivolumab 8Neoadjuvant Therapy 8Induction Chemotherapy 8fludarabine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Biopsy × Head & Neck × Clear all
NCT06199947 2024-01-10

Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma

Poitiers University Hospital

Phase NA Unknown
119 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05211427 2023-03-15

Bitter Taste Receptors in Oropharynx Cancer

Technische Universität Dresden

Phase NA Unknown
20 enrolled
Head & Neck

Oropharyngeal Neoplasms

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase NA Unknown
12 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01512212 2012-01-19

fnab

SB Istanbul Education and Research Hospital

Phase NA Unknown
40 enrolled
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

NCT00357617 2010-12-24

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 1/2 Unknown
24 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡